BEI
UTHR icon

Benjamin Edwards Inc’s United Therapeutics UTHR Stock Holding History

Benjamin Edwards Inc’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$256K Buy
+473
New +$266K ﹤0.01% 1300

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Benjamin Edwards Inc's UTHR Position: Q2 2026 in Review

Benjamin Edwards Inc opened a new position in United Therapeutics (UTHR) in Q2 2026: 473 shares worth $256K. The stake represents ﹤0.01% of the portfolio and ranks #1300 among its holdings.

875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Benjamin Edwards Inc held 473 shares of United Therapeutics worth $256K as of Q2 2026.
  • United Therapeutics was a new Benjamin Edwards Inc position in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Benjamin Edwards Inc's portfolio in Q2 2026, its #1300 holding.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Benjamin Edwards Inc's 13F filing for Q2 2026, filed 24 Jul 2026.